Expanding the potential of monoclonal antibodies against interleukin-4 and interleukin-13 in genodermatoses: A case series on the efficacy and safety of dupilumab in epidermolysis bullosa and ichthyosis
Saved in:
| Main Authors: | Francesca Caroppo, MD, Roberto Mazzetto, MD, Elisa Milan, MD, Fortunato Cassalia, MD, Anna Belloni Fortina, MD |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-06-01
|
| Series: | JAAD Case Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2352512625001031 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Successful treatment of familial cases of epidermolysis bullosa pruriginosa with dupilumab
by: Maya Kaga, et al.
Published: (2025-04-01) -
Real–world Experience with JAK Inhibitors and Dupilumab in Dystrophic Epidermolysis Bullosa: A Case Report and Literature Review
by: Shihua Ling, et al.
Published: (2025-05-01) -
Emerging DNA & RNA editing strategies for the treatment of epidermolysis bullosa
by: Ulrich Koller, et al.
Published: (2024-12-01) -
Pregnancy and childbirth in epidermolysis bullosa: A clinical case
by: M. A. Meretukova, et al.
Published: (2025-04-01) -
Systematic review on antipruritic therapies for patients with Epidermolysis bullosa
by: Tobias Welponer, et al.
Published: (2024-12-01)